{"title":"药物警戒是药物监管系统的关键组成部分","authors":"Igor Valerievich Korobkin","doi":"10.33920/med-13-2206-02","DOIUrl":null,"url":null,"abstract":"Information for control objects that are assigned risk categories is collected, processed, analyzed and recorded. The pharmaceutical manufacturer enters into an agreement with the recipient of the products on the exchange of data on the safety of such products in order to identify and study possible problems related to the safety of use, as well as to confirm social responsibility for the safety of drugs put into circulation.","PeriodicalId":12259,"journal":{"name":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacovigilance as a key component of drug regulatory systems\",\"authors\":\"Igor Valerievich Korobkin\",\"doi\":\"10.33920/med-13-2206-02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Information for control objects that are assigned risk categories is collected, processed, analyzed and recorded. The pharmaceutical manufacturer enters into an agreement with the recipient of the products on the exchange of data on the safety of such products in order to identify and study possible problems related to the safety of use, as well as to confirm social responsibility for the safety of drugs put into circulation.\",\"PeriodicalId\":12259,\"journal\":{\"name\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33920/med-13-2206-02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33920/med-13-2206-02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pharmacovigilance as a key component of drug regulatory systems
Information for control objects that are assigned risk categories is collected, processed, analyzed and recorded. The pharmaceutical manufacturer enters into an agreement with the recipient of the products on the exchange of data on the safety of such products in order to identify and study possible problems related to the safety of use, as well as to confirm social responsibility for the safety of drugs put into circulation.